Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)

INTRODUCTION: There is an urgent need to identify patients with bladder cancer (BC) who are at high risk of recurrence or progression. Calgranulin A is a strong marker for muscle-invasive or advanced BC and recent studies have shown its potential for identifying patients at risk even in non-muscle-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicklas, André P., Kramer, Mario W., Serth, Jürgen, Hennenlotter, Jörg, Hupe, Marie C., Reimer, Daniel U., Stenzl, Arnulf, Merseburger, Axel S., Kuczyk, Markus A., von Klot, Christoph-Alexander J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224005/
https://www.ncbi.nlm.nih.gov/pubmed/30232708
http://dx.doi.org/10.1007/s12325-018-0789-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224005/
https://www.ncbi.nlm.nih.gov/pubmed/30232708
http://dx.doi.org/10.1007/s12325-018-0789-7

Ejemplares similares